Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.600
-0.056 (-8.49%)
Nov 21, 2024, 1:06 PM EST - Market open
Ensysce Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 4.15 | 1.12 | 3.15 | 12.26 | 0.19 | 0.34 |
Cash & Short-Term Investments | 4.15 | 1.12 | 3.15 | 12.26 | 0.19 | 0.34 |
Cash Growth | 183.64% | -64.30% | -74.34% | 6215.06% | -43.14% | - |
Receivables | 1.78 | 0.1 | 0.28 | 0.44 | - | 0.17 |
Prepaid Expenses | 3.15 | 0.51 | 0.55 | 0.81 | 0.02 | 0.03 |
Other Current Assets | - | 0.55 | 1.33 | 2.15 | 0.14 | 0.07 |
Total Current Assets | 9.09 | 2.29 | 5.3 | 15.66 | 0.35 | 0.62 |
Property, Plant & Equipment | - | - | - | - | 0 | 0 |
Other Long-Term Assets | 0.29 | 0.42 | 0.59 | 0.75 | 0 | 0.01 |
Total Assets | 9.38 | 2.71 | 5.89 | 16.42 | 0.35 | 0.62 |
Accounts Payable | 1.97 | 1.94 | 2.94 | 0.3 | 1.72 | 0.54 |
Accrued Expenses | 0.45 | 0.54 | 2.23 | 3.41 | 0.19 | 1.21 |
Short-Term Debt | 0.39 | 0.85 | 4.27 | - | 4.25 | 2.62 |
Current Portion of Long-Term Debt | - | - | - | 12.75 | - | - |
Current Portion of Leases | - | - | 0.03 | 0.02 | 0.03 | - |
Current Unearned Revenue | - | - | - | - | 0.16 | 0.28 |
Other Current Liabilities | - | - | - | - | 0.67 | 2.65 |
Total Current Liabilities | 2.8 | 3.33 | 9.46 | 16.48 | 7.01 | 7.3 |
Long-Term Debt | - | - | 0.14 | 4.44 | - | - |
Other Long-Term Liabilities | 0 | 0.03 | 0.31 | 3.65 | - | - |
Total Liabilities | 2.8 | 3.36 | 9.91 | 24.58 | 7.01 | 7.3 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0.01 |
Additional Paid-In Capital | 132.89 | 121.23 | 107.22 | 77.97 | 49.52 | 49.33 |
Retained Earnings | -125.98 | -121.56 | -110.93 | -85.85 | -55.96 | -56.02 |
Total Common Equity | 6.91 | -0.32 | -3.71 | -7.88 | -6.44 | -6.68 |
Minority Interest | -0.33 | -0.33 | -0.32 | -0.28 | -0.22 | - |
Shareholders' Equity | 6.58 | -0.65 | -4.03 | -8.16 | -6.66 | -6.68 |
Total Liabilities & Equity | 9.38 | 2.71 | 5.89 | 16.42 | 0.35 | 0.62 |
Total Debt | 0.39 | 0.85 | 4.43 | 17.21 | 4.27 | 2.62 |
Net Cash (Debt) | 3.77 | 0.27 | -1.29 | -4.95 | -4.08 | -2.28 |
Net Cash Per Share | 0.58 | 0.12 | -7.15 | -58.91 | -59.27 | -2.28 |
Filing Date Shares Outstanding | 19.57 | 7.33 | 1.29 | 0.25 | 239.47 | 1 |
Total Common Shares Outstanding | 19.57 | 3.15 | 0.53 | 0.1 | 239.47 | 1 |
Working Capital | 6.29 | -1.04 | -4.17 | -0.82 | -6.66 | -6.68 |
Book Value Per Share | 0.35 | -0.10 | -6.95 | -76.73 | -0.03 | -6.69 |
Tangible Book Value | 6.91 | -0.32 | -3.71 | -7.88 | -6.44 | -6.68 |
Tangible Book Value Per Share | 0.35 | -0.10 | -6.95 | -76.73 | -0.03 | -6.69 |
Source: S&P Capital IQ. Standard template. Financial Sources.